Evidence map›Paper›PMID 33186163›Full record

ReviewAnesthesia and analgesia2020

Perioperative Cardioprotection: General Mechanisms and Pharmacological Approaches.

Carolin Torregroza, Annika Raupach, Katharina Feige, Nina C Weber, Markus W Hollmann, Ragnar Huhn

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Anesthesia and analgesia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Carolin TorregrozaFrom the Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany.
Annika RaupachFrom the Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany.
Katharina FeigeFrom the Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany.
Nina C WeberDepartment of Anesthesiology, Amsterdam University Medical Centers (AUMC), Amsterdam, the Netherlands.
Markus W HollmannDepartment of Anesthesiology, Amsterdam University Medical Centers (AUMC), Amsterdam, the Netherlands.
Ragnar HuhnFrom the Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany.
Düsseldorf University Hospital · DEHeinrich Heine University Düsseldorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardioprotection encompasses a variety of strategies protecting the heart against myocardial injury that occurs during and after inadequate blood supply to the heart during myocardial infarction. While restoring reperfusion is crucial for salvaging myocardium from further damage, paradoxically, it itself accounts for additional cell death-a phenomenon named ischemia/reperfusion injury. Therefore, therapeutic strategies are necessary to render the heart protected against myocardial infarction. Ischemic pre- and postconditioning, by short periods of sublethal cardiac ischemia and reperfusion, are still the strongest mechanisms to achieve cardioprotection. However, it is highly impractical and far too invasive for clinical use. Fortunately, it can be mimicked pharmacologically, for example, by volatile anesthetics, noble gases, opioids, propofol, dexmedetomidine, and phosphodiesterase inhibitors. These substances are all routinely used in the clinical setting and seem promising candidates for successful translation of cardioprotection from experimental protocols to clinical trials. This review presents the fundamental mechanisms of conditioning strategies and provides an overview of the most recent and relevant findings on different concepts achieving cardioprotection in the experimental setting, specifically emphasizing pharmacological approaches in the perioperative context.

Indexed as

Analgesics, OpioidCardiotonic AgentsHumansIschemic Preconditioning, MyocardialMyocardial Reperfusion InjuryPerioperative CarePhosphodiesterase 3 InhibitorsPostoperative ComplicationsAnalgesics, OpioidCardiotonic AgentsPhosphodiesterase 3 Inhibitors

Identifiers

PMID33186163
OpenAlexW3099084206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.